A multi-centre phase I/II proof-of-concept clinical trial exploring the effects of early intensive antiretroviral therapy (ART) on achieving HIV remission in neonates. Started in June 2015 at Baylor-Uganda’s Centre of Excellence HIV clinic in Mulago, this ongoing study will also assess the safety and pharmacokinetics of early intensive ART in neonates. For more information about the study, follow this link